- EmployersExpands insured access to a broad range of fertility services (including IVF and preservation) for people covered by em…
- StatesStandardizes benefit parity by tying fertility coverage to existing obstetrical coverage and limits relative cost‑shari…
- WorkersIncreased demand for clinical and laboratory services related to reproduction (fertility clinics, embryology labs, repr…
Access to Fertility Treatment and Care Act
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
The Access to Fertility Treatment and Care Act requires group health plans, individual and group health insurance issuers, federal programs (FEHB, TRICARE, Medicare, Medicaid), the Department of Veterans Affairs, and other covered plans to provide coverage for a broad set of fertility treatments whenever the plan already covers obstetrical services. The bill defines fertility treatment to include preservation of oocytes/sperm/embryos, artificial insemination, assisted reproductive technologies (including IVF), genetic testing of embryos, fertility medications, gamete donation, and additional services the HHS Secretary deems appropriate.
Scope and mandate: liberals view the federal mandate as necessary to expand access, conservatives view it as federal overreach and an undue employer/insurer mandate.
Relative to its intended legislative type, this bill is a well‑scoped substantive statutory package that systematically amends multiple federal statutes to require fertility treatment coverage where obstetrical services are provided.
The Access to Fertility Treatment and Care Act requires group health plans, individual and group health insurance issuers, federal programs (FEHB, TRICARE, Medicare, Medicaid), the Department of Veterans Affairs, and other covered plans to provide coverage for a broad set of fertility treatments whenever the plan already covers obstetrical services.
The bill defines fertility treatment to include preservation of oocytes/sperm/embryos, artificial insemination, assisted reproductive technologies (including IVF), genetic testing of embryos, fertility medications, gamete donation, and additional services the HHS Secretary deems appropriate.
It bars discriminatory limitations and incentives to deter use, restricts cost-sharing so it may not exceed that applicable to other medical services, requires notices to enrollees, and directs agencies to issue implementing regulations; several effective dates and a collective bargaining exception are specified.
Judged on content alone, this is a consequential, nationwide mandate with substantial fiscal and administrative consequences. While it contains some compromise elements (limited to plans with obstetrical benefits, phased implementation, and collective-bargaining/state-delay exceptions) it still expands federal coverage obligations across many programs and private plans. Such broad mandates with high cost implications and ethical sensitivities have historically been harder to enact without broad consensus, appropriation offsets, or narrower targeting.
Relative to its intended legislative type, this bill is a well‑scoped substantive statutory package that systematically amends multiple federal statutes to require fertility treatment coverage where obstetrical services are provided. It provides clear definitions, integrates into existing statutory frameworks, and assigns regulatory responsibilities and effective dates.
Scope and mandate: liberals view the federal mandate as necessary to expand access, conservatives view it as federal overreach and an undue employer/insurer mandate.
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- EmployersInsurers and self‑insured employers may face higher benefit costs that could translate into increased premiums, contrib…
- Federal agenciesFederal programs (Medicare, VA, TRICARE, FEHB) and state Medicaid are likely to face increased direct spending or admin…
- Federal agenciesImplementation will create regulatory and administrative burdens for health plans, federal agencies, and providers (rul…
Why the argument around this bill splits.
Scope and mandate: liberals view the federal mandate as necessary to expand access, conservatives view it as federal overreach and an undue employer/insurer mandate.
A mainstream liberal would likely view the bill favorably as a major expansion of reproductive health care access that closes gaps for people who currently lack fertility coverage, including same-sex couples, single parents by choice, and those who need preservation for medical reasons.
They would read the broad statutory definition and the clause removing an infertility diagnosis requirement as intentionally inclusive.
The liberal persona would welcome Medicare, VA, TRICARE, and Medicaid inclusion and the anti‑discrimination language, while flagging the interim-final regulatory authority as an implementation detail to monitor.
A moderate/centrist would see clear public-interest goals in standardizing fertility coverage and closing federal program gaps, but would also be cautious about cost, implementation complexity, and unintended effects on employers, insurers, and premiums.
They would appreciate the bill’s attempt to align cost-sharing with obstetrical benefits and its stepwise effective dates, but would want better fiscal estimates and operational details.
The centrist persona would likely favor the core access goals while pushing for measured implementation, oversight, and possibly limited accommodations for particular programs or employers.
A mainstream conservative would likely oppose the bill in its current form as an expansive federal mandate that forces employers and insurers to cover a broad set of fertility services, interferes with private plan design, and increases federal program spending.
They would be concerned about government overreach, the absence of robust conscience or religious exemptions for employers/providers, and the potential for higher premiums and taxpayer costs.
Some conservative supporters might acknowledge benefits for veterans and military families, but overall the persona would view the measure as requiring significant changes to be acceptable.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Judged on content alone, this is a consequential, nationwide mandate with substantial fiscal and administrative consequences. While it contains some compromise elements (limited to plans with obstetrical benefits, phased implementation, and collective-bargaining/state-delay exceptions) it still expands federal coverage obligations across many programs and private plans. Such broad mandates with high cost implications and ethical sensitivities have historically been harder to enact without broad consensus, appropriation offsets, or narrower targeting.
- No Congressional Budget Office (CBO) or cost estimate is included in the bill text; the magnitude of federal and private-sector fiscal impact is therefore unclear and crucial to legislative calculations.
- Political coalition dynamics (which members would support or oppose the bill) are not present in the text; floor prospects depend heavily on those external dynamics.
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Scope and mandate: liberals view the federal mandate as necessary to expand access, conservatives view it as federal overreach and an undue…
Judged on content alone, this is a consequential, nationwide mandate with substantial fiscal and administrative consequences. While it cont…
Relative to its intended legislative type, this bill is a well‑scoped substantive statutory package that systematically amends multiple federal statutes to require fertility treatment coverage where obstetrical services…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.